Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.7973
+0.072510.00%
Volume:1.37M
Turnover:1.08M
Market Cap:66.79M
PE:-0.27
High:0.8112
Open:0.7400
Low:0.7400
Close:0.7248
Loading ...

Sutro Biopharma Names New CEO; Plans to Reduce Workforce by Nearly 50% After Portfolio Review

MT Newswires Live
·
14 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sutro Biopharma (STRO) and Generation Bio (GBIO)

TIPRANKS
·
14 Mar

Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Mar

Sutro Biopharma Review Results in 50% Workforce Reduction, CEO Transition

Dow Jones
·
14 Mar

Sutro Biopharma FY 2024 GAAP EPS $(2.96) Misses $(2.92) Estimate, Sales $62.043M Beat $59.004M Estimate

Benzinga
·
14 Mar

BRIEF-Sutro Biopharma FY Revenue USD 62.043 Million

Reuters
·
14 Mar

Sutro Biopharma Inc - Cash Payments Associated With Restructuring Are Estimated to Be $40 to $45 Mln

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Jane Chung, President and COO, to Succeed BILL Newell as CEO and Board Director

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Will Reduce Its Organizational Headcount by Nearly 50 Percent

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Intends to Exit Its Internal Gmp Manufacturing Facility by Year-End

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of Its Next-Generation ADC Pipeline

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc: Cash Runway Expected Into at Least Q4 2026

THOMSON REUTERS
·
14 Mar

Press Release: Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights

Dow Jones
·
14 Mar

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

GlobeNewswire
·
14 Mar

Oculis Holding AG (OCS) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
12 Mar

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
04 Mar

We're Not Very Worried About Sutro Biopharma's (NASDAQ:STRO) Cash Burn Rate

Simply Wall St.
·
22 Jan

Sutro Biopharma (STRO) Gets a Buy from Bank of America Securities

TIPRANKS
·
16 Jan

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
08 Jan

Sutro Biopharma and Boehringer Ingelheim Bioxcellence™ Collaboration: Established First-in-Class Cell-Free Capabilities at Commercial Scale

THOMSON REUTERS
·
07 Jan